Fuchs' heterochromic iridocyclitis complicated by hypertonia: a case report

Research Area: Medicine Authors
zahira HAZIL* salma HASSINA ihssan HASNAOUI louai SERGHINI elhassan ABDALLAH
Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat RABAT MOROCCO

Abstract
Fuchs’ heterochromic iridocyclitis or Fuchs’ syndrome is a fairly common etiology of uveitis, but its pathophysiological mechanism remains poorly understood. The positive diagnosis remains clinical. Ocular hypertonia can complicate the disease, necessitating medical management and sometimes recourse to trabeculectomy. We report the case of a young patient with Fuchs heterochromia complicated by ocular hypertonia.

Keywords
Heterochromic iridocyclitis –hypertonia- catract

Doi : https://doi.org/10.5281/zenodo.10512692

PDF File


Cite
HAZIL, Z., HASSINA, S., HASNAOUI, I., SERGHINI, L., & ABDELLAH, E. H. (2023). FUCHS' HETEROCHROMIC IRIDOCYCLITIS COMPLICATED BY HYPERTONIA: A CASE REPORT. International Journal of Science, Applications and Prosperity, 1(1), 13‑18.

Licence
Creative Commons Attribution Share Alike 4.0 International

References
[1] M. D. Becker and M. Zierhut, “[Fuchs uveitis syndrome--heterochromia is no ‘conditio sine qua non’],” Ophthalmologe, vol. 102, no. 7, pp. 733–742; quiz 743–744, Jul. 2005, doi: 10.1007/s00347-005-1237-z.

[2] C. D. Quentin and H. Reiber, “Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor,” Am J Ophthalmol, vol. 138, no. 1, pp. 46–54, Jul. 2004, doi: 10.1016/j.ajo.2004.02.055.

[3] L. Gordon, “Fuch’s heterochromic cyclitis: new clues regarding pathogenesis,” Am J Ophthalmol, vol. 138, no. 1, pp. 133–134, Jul. 2004, doi: 10.1016/j.ajo.2004.03.031.

[4] A. D. Birnbaum et al., “Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program,” Am J Ophthalmol, vol. 144, no. 3, pp. 424–428, Sep. 2007, doi: 10.1016/j.ajo.2007.05.026.

[5] N. Teyssot, N. Cassoux, P. Lehoang, and B. Bodaghi, “Fuchs heterochromic cyclitis and ocular toxocariasis,” Am J Ophthalmol, vol. 139, no. 5, pp. 915–916, May 2005, doi: 10.1016/j.ajo.2004.10.054.

[6] M. Toledo de Abreu, R. Belfort, and P. S. Hirata, “Fuchs’ heterochromic cyclitis and ocular toxoplasmosis,” Am J Ophthalmol, vol. 93, no. 6, pp. 739–744, Jun. 1982, doi: 10.1016/0002-9394(82)90470-6.

[7] T. J. Liesegang, “Clinical features and prognosis in Fuchs’ uveitis syndrome,” Arch Ophthalmol, vol. 100, no. 10, pp. 1622–1626, Oct. 1982, doi: 10.1001/archopht.1982.01030040600009.

[8] K. Norrsell and L. Sjödell, “Fuchs’ heterochromic uveitis: a longitudinal clinical study,” Acta Ophthalmol, vol. 86, no. 1, pp. 58–64, Feb. 2008, doi: 10.1111/j.1600-0420.2007.00990.x.

[9] Fuchs E. Uber komplikationen der Heterochromie. Z Augenheikd 1906,15:191-212

[10] N. P. Jones, “Glaucoma in Fuchs’ heterochromic uveitis: Aetiology, management and outcome,” Eye, vol. 5, no. 6, pp. 662–667, Nov. 1991, doi: 10.1038/eye.1991.122.

[11] E. La Hey, G. S. Baarsma, J. De Vries, and A. Kijlstra, “Clinical analysis of Fuchs’ heterochromic cyclitis,” Doc Ophthalmol, vol. 78, no. 3–4, pp. 225–235, 1991, doi: 10.1007/BF00165685.

[12] M. S. Wertheim et al., “In vivo confocal microscopy of keratic precipitates,” Arch Ophthalmol, vol. 122, no. 12, pp. 1773–1781, Dec. 2004, doi: 10.1001/archopht.122.12.1773.

[13] A. Franceschetti, “Heterochromic cyclitis: Fuchs’ syndrome,” Am J Ophthalmol, vol. 39, no. 4 Pt 2, pp. 50–58, Apr. 1955, doi: 10.1016/0002-9394(55)90152-5.

[14] A. Rothova, E. La Hey, G. S. Baarsma, and A. C. Breebaart, “Iris nodules in Fuchs’ heterochromic uveitis,” Am J Ophthalmol, vol. 118, no. 3, pp. 338–342, Sep. 1994, doi: 10.1016/s0002-9394(14)72958-7.

[15] A. Rothova, “The riddle of fuchs heterochromic uveitis,” Am J Ophthalmol, vol. 144, no. 3, pp. 447–448, Sep. 2007, doi: 10.1016/j.ajo.2007.06.024.

[16] W. Daus, J. Schmidbauer, P. Buschendorff, M. R. Tetz, and H. E. Völcker, “Results of extracapsular cataract extraction with intraocular lens implantation in eyes with uveitis and Fuchs’ heterochromic iridocyclitis,” Ger J Ophthalmol, vol. 1, no. 6, pp. 399–402, 1992.

[17] R. A. Scott, P. M. Sullivan, G. W. Aylward, C. E. Pavésio, and D. G. Charteris, “The effect of pars plana vitrectomy in the management of Fuchs heterochromic cyclitis,” Retina, vol. 21, no. 4, pp. 312–316, 2001, doi: 10.1097/00006982-200108000-00003.

[18] M. Amsler and F. Verrey, “[Fuchs heterochromia and vascular fragility],” Ophthalmologica, vol. 111, no. 2–3, pp. 177–181, 1946, doi: 10.1159/000300320.

[19] T. J. Liesegang, “Clinical features and prognosis in Fuchs’ uveitis syndrome,” Arch Ophthalmol, vol. 100, no. 10, pp. 1622–1626, Oct. 1982, doi: 10.1001/archopht.1982.01030040600009.